Effectiveness of personalised risk information and taster sessions to increase the uptake of smoking cessation services (Start2quit): a randomised controlled trial

被引:0
|
作者
Gilbert, Hazel [1 ]
Sutton, Stephen [2 ]
Morris, Richard [1 ]
Petersen, Irene [1 ]
Galton, Simon [3 ]
Wu, Qi [4 ]
Parrott, Steve [4 ]
Nazareth, Irwin [1 ]
机构
[1] UCL, Res Dept Primary Care & Populat Hlth, London, England
[2] Univ Cambridge, Inst Publ Hlth, Cambridge, England
[3] NHS Camden, Smokefree Camden Publ Hlth, London, England
[4] Univ York, Dept Hlth Sci, York, N Yorkshire, England
来源
LANCET | 2017年 / 389卷 / 10071期
基金
美国国家卫生研究院;
关键词
SMOKERS; PREDICTORS; HEALTH;
D O I
10.1016/S0140-6736(16)32379-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background National Health Service Stop Smoking Services (SSSs) off er help to smokers motivated to quit; however, attendance rates are low and recent figures show a downward trend. We aimed to assess the effectiveness of a two-component personalised intervention on attendance at SSSs. Methods We did this randomised controlled trial in 18 SSSs in England. Current smokers (aged >= 16 years) were identified from medical records in 99 general practices and invited to participate by their general practitioner. Individuals who gave consent, were motivated to quit, and had not attended the SSS within the past 12 months, were randomly assigned (3:2), via computer-generated randomisation with permuted blocks (block size of five), to receive either an individually tailored risk letter and invitation to attend a no-commitment introductory session run by the local SSS (intervention group) or a standard generic letter advertising the local SSS (control group). Randomisation was stratified by sex. Masking of participants to receipt of a personal letter and invitation to a taster session was not possible. The personal letter was generated by a research assistant, but the remainder of the research team were masked to group allocation. General practitioners, practice staff, and SSS advisers were unaware of their patients' allocation. The primary outcome was attendance at the first session of an SSS course within 6 months from randomisation. We did analysis by intention to treat. This trial is registered with Current Controlled Trials, number ISRCTN 76561916. Findings Recruitment, collection of baseline data, delivery of the intervention, and follow up of participants took place between Jan 31, 2011, and July 12, 2014. We randomly assigned 4384 smokers to the intervention group (n=2636) or the control group (n=1748); 4383 participants comprised the intention-to-treat population. Attendance at the first session of an SSS course was significantly higher in the intervention group than in the control group (458 [17.4%] vs 158 [9.0%] participants; unadjusted odds ratio 2.12 [ 95% CI 1.75-2.57]; p<0.0001). Interpretation Delivery of personalised risk information alongside an invitation to an introductory session more than doubled the odds of attending the SSS compared with a standard generic invitation to contact the service. This result suggests that a more proactive approach, combined with an opportunity to experience local services, can reduce patient barriers to receiving treatment and has high potential to increase uptake. Funding National Institutes of Health Research Health Technology Assessment. Copyright (C) The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY license.
引用
收藏
页码:823 / 833
页数:11
相关论文
共 16 条
  • [1] Cost-effectiveness of personal tailored risk information and taster sessions to increase the uptake of the NHS stop smoking services: the Start2quit randomized controlled trial
    Wu, Qi
    Gilbert, Hazel
    Nazareth, Irwin
    Sutton, Stephen
    Morris, Richard
    Petersen, Irene
    Galton, Simon
    Parrott, Steve
    [J]. ADDICTION, 2018, 113 (04) : 708 - 718
  • [2] Start2quit: a randomised clinical controlled trial to evaluate the effectiveness and cost- effectiveness of using personal tailored risk information and taster sessions to increase the uptake of the NHS Stop Smoking Services
    Gilbert, Hazel
    Sutton, Stephen
    Morris, Richard
    Petersen, Irene
    Wu, Qi
    Parrott, Steve
    Galton, Simon
    Kale, Dimitra
    Magee, Molly Sweeney
    Gardner, Leanne
    Nazareth, Irwin
    [J]. HEALTH TECHNOLOGY ASSESSMENT, 2017, 21 (03) : 1 - +
  • [3] Evaluating the effectiveness of using personal tailored risk information and taster sessions to increase the uptake of smoking cessation services: study protocol for a randomised controlled trial
    Hazel Gilbert
    Stephen Sutton
    Richard Morris
    Steve Parrot
    Simon Galton
    Irwin Nazareth
    [J]. Trials, 13
  • [4] Evaluating the effectiveness of using personal tailored risk information and taster sessions to increase the uptake of smoking cessation services: study protocol for a randomised controlled trial
    Gilbert, Hazel
    Sutton, Stephen
    Morris, Richard
    Parrot, Steve
    Galton, Simon
    Nazareth, Irwin
    [J]. TRIALS, 2012, 13
  • [5] Effectiveness of a text messaging-based smoking cessation intervention (Happy Quit) in China: a randomised controlled trial
    Tang, Jinsong
    Liao, Yanhui
    [J]. LANCET, 2018, 392 : 6 - 6
  • [6] Effectiveness of nicotine replacement therapy sample at outdoor smoking hotspots for initiating quit attempts and use of smoking cessation services: a protocol for a cluster randomised controlled trial
    Cheung, Yee Tak Derek
    Chan, Ching Han Helen
    Ho, Kin Sang
    Tang, Celeste
    Lau, Chloe Wing Hei
    Li, William Ho Cheung
    Wang, Man Ping
    Lam, Tai Hing
    [J]. BMJ OPEN, 2020, 10 (04):
  • [7] RECRUITMENT STRATEGIES AND LESSONS FROM THE WE CAN QUIT2 TRIAL - A SMOKING CESSATION COMMUNITY-BASED CLUSTER RANDOMISED CONTROLLED TRIAL FOR WOMEN LIVING IN DISADVANTAGED AREAS OF IRELAND
    Burke, E.
    O'Connell, N.
    Darker, C.
    Vance, J.
    Dougall, N.
    Bauld, L.
    Hayes, C.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2019, 73 : A90 - A91
  • [8] Recruitment of women from disadvantaged areas to a smoking cessation intervention: preliminary findings from the We Can Quit2 (WCQ2) cluster randomised controlled trial
    Hayes, C.
    [J]. EUROPEAN JOURNAL OF PUBLIC HEALTH, 2019, 29 : 238 - 238
  • [9] Assessing the efficacy and impact of a personalised smoking cessation intervention among type 2 diabetic smokers: study protocol for an open-label randomised controlled trial (DISCGO-RCT)
    Clair, Carole
    Augsburger, Aurelie
    Birrer, Priska
    Locatelli, Isabella
    Schwarz, Joelle
    Greub, Gilbert
    Zanchi, Anne
    Jacot-Sadowski, Isabelle
    Puder, Jardena J.
    [J]. BMJ OPEN, 2020, 10 (11):
  • [10] WE CAN QUIT2-PRELIMINARY RESULTS OF A PILOT CLUSTER RANDOMISED CONTROLLED TRIAL OF A COMMUNITY-BASED INTERVENTION ON SMOKING CESSATION FOR WOMEN LIVING IN DISADVANTAGED AREAS OF IRELAND
    Hayes, C. B.
    Patterson, J.
    Burke, E.
    O'Connell, N.
    Dobble, F.
    Vance, J.
    Darker, C.
    Devane, D.
    Bauld, L.
    Dougall, N.
    [J]. JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2020, 74 : A6 - A7